| 000 | 01794 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250513232510.0 | ||
| 264 | 0 | _c20010405 | |
| 008 | 200104s 0 0 eng d | ||
| 022 | _a0028-3878 | ||
| 024 | 7 |
_a10.1212/wnl.56.4.445 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMendell, J R | |
| 245 | 0 | 0 |
_aRandomized controlled trial of IVIg in untreated chronic inflammatory demyelinating polyradiculoneuropathy. _h[electronic resource] |
| 260 |
_bNeurology _cFeb 2001 |
||
| 300 |
_a445-9 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, U.S. Gov't, P.H.S. | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xadverse effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aNeural Conduction _xphysiology |
| 650 | 0 | 4 |
_aPolyradiculoneuropathy, Chronic Inflammatory Demyelinating _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 700 | 1 | _aBarohn, R J | |
| 700 | 1 | _aFreimer, M L | |
| 700 | 1 | _aKissel, J T | |
| 700 | 1 | _aKing, W | |
| 700 | 1 | _aNagaraja, H N | |
| 700 | 1 | _aRice, R | |
| 700 | 1 | _aCampbell, W W | |
| 700 | 1 | _aDonofrio, P D | |
| 700 | 1 | _aJackson, C E | |
| 700 | 1 | _aLewis, R A | |
| 700 | 1 | _aShy, M | |
| 700 | 1 | _aSimpson, D M | |
| 700 | 1 | _aParry, G J | |
| 700 | 1 | _aRivner, M H | |
| 700 | 1 | _aThornton, C A | |
| 700 | 1 | _aBromberg, M B | |
| 700 | 1 | _aTandan, R | |
| 700 | 1 | _aHarati, Y | |
| 700 | 1 | _aGiuliani, M J | |
| 773 | 0 |
_tNeurology _gvol. 56 _gno. 4 _gp. 445-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/wnl.56.4.445 _zAvailable from publisher's website |
| 999 |
_c11160632 _d11160632 |
||